1.
Diabetes Res Clin Pract
; 179: 109022, 2021 Sep.
Artículo
en Inglés
| MEDLINE
| ID: mdl-34450248
RESUMEN
In patients with autoimmune diabetes no significant differences were observed in glucose control, expressed as time in range evaluated by continuous glucose monitoring comparing the 3 days after Sars-Cov2 vaccine with the 14 days preceding the vaccine.